Amoxicillin And Clavulanate Potassium
Pricing Report NDC 72508-221-14

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Amoxicillin And Clavulanate Potassium (NDC 72508-221-14) is $0.27733 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 17, 2021.

As a provided by Neopharma Inc, this medication is distributed in a 20 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.27733
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Mar 17, 2021
Billable Units
20 EA
Estimated Package Price
$5.55
Data Status
As of Mar 31, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
72508-221-14
Description
20 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2020, the NADAC wholesale price for (NDC ) has moved within a range of $0.27523 to $0.39836 per EA. Over this 1 year and 2 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.2752 - $0.3984
Market Volatility
44.74% Variance
Latest Trend
0.80%
Date Unit Price Unit Source Method Rate
Mar 17, 2021 $0.27733 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 17, 2021 $0.27958 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 20, 2021 $0.27523 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 23, 2020 $0.28325 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 18, 2020 $0.31113 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 21, 2020 $0.29298 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 23, 2020 $0.29416 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2020 $0.30139 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2020 $0.29195 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2020 $0.39836 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2020 $0.38612 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2020 $0.39085 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $0.36771 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2020 $0.39582 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.31868 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 01, 2020 $0.33160 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026